Early Prediction of ICU Hypotension Using Machine Learning (ICU-HypoAI)
A Prospective Observational Machine Learning Study for the Early Prediction of Hypotension in Adult Intensive Care Unit Patients
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Hypotension is a frequent hemodynamic event in critically ill patients and may occur before clear clinical deterioration is recognized. Earlier identification of patients at risk may support closer clinical attention and more timely evaluation. This study is designed as a prospective, observational machine learning study in adult intensive care unit patients.
Routinely available ICU data will be collected at five-minute intervals, including systolic, mean, and diastolic non-invasive blood pressure, heart rate, medication-dose entries, and fluid-balance records. These data will be used to construct time-dependent features reflecting recent values, short-term changes, and rolling trends. Hypotension will be defined at each five-minute time point as systolic blood pressure below 90 mmHg, mean arterial pressure below 65 mmHg, or diastolic blood pressure below 60 mmHg.
The primary prediction horizon will be 30 minutes. Separate secondary analyses will evaluate 5- and 15-minute prediction horizons. A gradient-boosted decision-tree model will be developed and internally validated using patient-level data partitioning to avoid assigning observations from the same patient to both training and validation sets. Model performance will be assessed using discrimination, classification performance, and calibration measures. Feature-importance analyses will be used to describe the variables contributing to model predictions.
The study is observational. No treatment, medication, device, alarm, or clinical decision will be assigned by the study protocol. The prediction model will be developed and evaluated using collected data and will not be used to guide real-time patient management during the study period.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Kütahya
-
Kütahya, Kütahya, Turquie (Türkiye), 43100
- Kütahya City Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Age 18 years or older
- Admission to the adult intensive care unit during the study period
- Length of stay in the intensive care unit of at least 24 hours
- Availability of routine intensive care unit monitoring data
- Availability of non-invasive blood pressure and heart rate measurements recorded during ICU monitoring
- Availability of medication-dose and/or fluid-balance records during ICU monitoring
Exclusion Criteria:
- Age younger than 18 years
- Length of stay in the intensive care unit of less than 24 hours
- Absence of usable blood pressure monitoring data
- Records with irrecoverable timestamp inconsistencies
- Insufficient monitoring duration for feature construction and future outcome labeling
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Adult Intensive Care Unit Patients
Adult patients admitted to the intensive care unit who are monitored during routine clinical care.
Routinely collected non-invasive blood pressure, heart rate, medication-dose, and fluid-balance data will be used for machine learning model development and internal validation.
No treatment or clinical intervention will be assigned by the study protocol.
|
Routinely collected intensive care unit data, including non-invasive blood pressure, heart rate, medication-dose records, and fluid-balance data, will be recorded and analyzed for development and internal validation of a machine learning model.
The study does not assign any treatment, medication, device, alarm, or clinical decision.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Area Under the Receiver Operating Characteristic Curve for 30-Minute Hypotension Prediction
Délai: From enrollment through the end of ICU monitoring, up to 4 months
|
Discriminative performance of the machine learning model for predicting hypotension 30 minutes before its occurrence.
Hypotension will be defined as systolic blood pressure below 90 mmHg, mean arterial pressure below 65 mmHg, or diastolic blood pressure below 60 mmHg at a five-minute observation point.
|
From enrollment through the end of ICU monitoring, up to 4 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Area Under the Receiver Operating Characteristic Curve for 5- and 15-Minute Hypotension Prediction
Délai: From enrollment through the end of ICU monitoring, up to 4 months
|
Discriminative performance of separate machine learning models for predicting hypotension at 5-minute and 15-minute prediction horizons.
|
From enrollment through the end of ICU monitoring, up to 4 months
|
|
Classification Performance of the Hypotension Prediction Model
Délai: From enrollment through the end of ICU monitoring, up to 4 months
|
Classification performance of the machine learning model will be assessed using sensitivity, specificity, positive predictive value, negative predictive value, and F1 score at predefined classification thresholds.
|
From enrollment through the end of ICU monitoring, up to 4 months
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2026/03-15
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .